Cervical cancer primary prevention
|
Cervical cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cervical cancer primary prevention On the Web |
|
American Roentgen Ray Society Images of Cervical cancer primary prevention |
|
Risk calculators and risk factors for Cervical cancer primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview
Most effective and cost efficient primary prevention available for cervical cancer is vaccination against high risk strains of human papilloma virus, which are HPV 16 and 18 and is given to adoloscent and young women ideally before the sexual debut.
Primary Prevention
- Primary prevention method for cervical cancer is vaccination against HPV types 16 and 18, there are two type of FDA approved vaccines available in the market. These vaccines are most effective when it's given to women age 9 to 26 and young male population through age 21 according to CDC recommendation. [1]
- HPV vaccine also is recommended for following target poulation:
- Young homosexual or bisexual men who have sex with men through age 26
- HIV infected young adult who have weakened immune system through age 26
- Young adults who are transgender through age 26
References
- ↑ Markowitz, L. E.; Unger, E. R.; Saraiya, M. (2009). "Primary and Secondary Prevention of Cervical Cancer--Opportunities and Challenges". JNCI Journal of the National Cancer Institute. 101 (7): 439–440. doi:10.1093/jnci/djp044. ISSN 0027-8874.
- ↑ Grce M (November 2009). "Primary and secondary prevention of cervical cancer". Expert Rev. Mol. Diagn. 9 (8): 851–7. doi:10.1586/erm.09.64. PMID 19895230.